Veterinary and Comparative Oncology

Herausgeber

Wiley-Blackwell

International Standard Serial Number (ISSN )

1476-5810

Electronic International Standard Serial Number ( EISSN )

1476-5829

ISSN gedruckt

1476-5810

URL

http://www.bibliothek.uni-regensburg.de/ezeit/?2129634

Weitere Details

2024

Evaluation of the health-related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire.

2023

Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000-2021)

2021

Are B-symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B-cell lymphoma.

2021

Ki-67 assessment-agreeability between immunohistochemistry and flow cytometry in canine lymphoma

2021

Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma.

2021

Characterization of radio-sensitivity of canine oralmalignant melanoma cell lines and their secretion of cytokines.

2021

Downregulation of CD146 sensitizes radio-resistantcanine oral melanoma cell lines to irradiation.

2020

Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: an Italian Society of Veterinary Oncology study.

2019

Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour

2019

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms

2019

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

2019

In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours

2018

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

2017

Characterization of a PCR-based lymphocyte clonality assay as a complementary tool for the diagnosis of feline lymphoma.

2017

Detection of monoclonality in intestinal lymphoma with polymerase chain reaction for antigen receptor gene rearrangement analysis to differentiate from enteritis in dogs.

2017

Gastric carcinoma in canines and humans, a review.

2017

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

2017

Melting curve analysis in canine lymphoma by calculating maximum fluorescence decrease.

2017

Mutation analysis and gene expression profiling of ocular melanomas in cats

2017

Pretreatment leukocyte ratios and concentrations as predictors of outcome in dogs with cutaneous mast cell tumours

2017

S100A4 (metastasin) positive mesenchymal canine mammary tumour spheroids reduce Tenascin C synthesis under DMSO exposure in vitro.

2014

Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.

2013

Canine intracranial neoplasms: Radiation therapy and survival analysis of 35 cases.

2013

Expression and Inhibition of Fibroblastic Growth Factor Receptors in canine sarcomas.

2008

Identifi cation of heat shock protein (Hsp32) as a novel therapeutic target in neoplastic mast cells.

2006

High-dose-rate brachytherapy for intranasal tumours in dogs: results of a pilot study.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2024

Evaluation of the health-related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire.

2023

Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000-2021)

2021

Are B-symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B-cell lymphoma.

2021

Ki-67 assessment-agreeability between immunohistochemistry and flow cytometry in canine lymphoma

2021

Prevalence and potentially prognostic value of C-circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma.

2021

Characterization of radio-sensitivity of canine oralmalignant melanoma cell lines and their secretion of cytokines.

2021

Downregulation of CD146 sensitizes radio-resistantcanine oral melanoma cell lines to irradiation.

2020

Outcome comparison between radiation therapy and surgery as primary treatment for dogs with periarticular histiocytic sarcoma: an Italian Society of Veterinary Oncology study.

2019

Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour

2019

Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms

2019

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.

2019

In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD-0332991) for treating canine mammary tumours

2018

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.

2017

Characterization of a PCR-based lymphocyte clonality assay as a complementary tool for the diagnosis of feline lymphoma.

2017

Detection of monoclonality in intestinal lymphoma with polymerase chain reaction for antigen receptor gene rearrangement analysis to differentiate from enteritis in dogs.

2017

Gastric carcinoma in canines and humans, a review.

2017

IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

2017

Melting curve analysis in canine lymphoma by calculating maximum fluorescence decrease.

2017

Mutation analysis and gene expression profiling of ocular melanomas in cats

2017

Pretreatment leukocyte ratios and concentrations as predictors of outcome in dogs with cutaneous mast cell tumours

2017

S100A4 (metastasin) positive mesenchymal canine mammary tumour spheroids reduce Tenascin C synthesis under DMSO exposure in vitro.

2014

Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.

2013

Canine intracranial neoplasms: Radiation therapy and survival analysis of 35 cases.

2013

Expression and Inhibition of Fibroblastic Growth Factor Receptors in canine sarcomas.

2008

Identifi cation of heat shock protein (Hsp32) as a novel therapeutic target in neoplastic mast cells.

2006

High-dose-rate brachytherapy for intranasal tumours in dogs: results of a pilot study.

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format